Skip to main content
Premium Trial:

Request an Annual Quote

Millennium and Wyeth Extend Central Nervous System Collaboration

Premium

CAMBRIDGE, Mass.--Millennium Pharmaceuticals announced that its collaboration with Wyeth-Ayerst Research in the area of central nervous system disorders will be extended for at least two more years. Millennium also revealed that it has provided Wyeth with a third novel candidate gene, the discovery of which activates an undisclosed milestone payment to Millennium. Under the original 1996 agreement, Wyeth agreed to pay Millennium up to $90 million in licensing fees and research payments to access genomic technologies and fund research, including human population genetic studies, aimed at developing novel treatments for a broad range of CNS diseases.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.